{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:57:38Z","timestamp":1776329858925,"version":"3.50.1"},"reference-count":25,"publisher":"Baskent University","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.6002\/ect.2023.0267","type":"journal-issue","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:44:45Z","timestamp":1771325085000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Alforaih N, Whittall-Garcia L, Touma Z. A review of lupus nephritis. J Appl Lab Med. 2022;7(6):1450-1467. doi:10.1093\/jalm\/jfac036","DOI":"10.1093\/jalm\/jfac036"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Scherlinger M, Mertz P, Sagez F, et al. Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. Autoimmun Rev. 2020;19(6):102531. doi:10.1016\/j.autrev.2020.102531","DOI":"10.1016\/j.autrev.2020.102531"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Siligato R, Gembillo G, Calabrese V, Conti G, Santoro D. Amyloidosis and glomerular diseases in familial Mediterranean fever. Medicina (Kaunas). 2021;57(10). doi:10.3390\/medicina57101049","DOI":"10.3390\/medicina57101049"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Honda S, Katsumata Y, Karasawa K, Yamanaka H, Harigai M. Management of end-stage renal disease associated with systemic rheumatic diseases. JMA J. 2020;3(1):20-28. doi:10.31662\/jmaj.2019-0020","DOI":"10.31662\/jmaj.2019-0020"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Chaudhry D, Chaudhry A, Peracha J, Sharif A. Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis. BMJ. 2022;376:e068769. doi:10.1136\/bmj-2021-068769","DOI":"10.1136\/bmj-2021-068769"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Wu MJ, Lo YC, Lan JL, et al. Outcome of lupus nephritis after entering into end-stage renal disease and comparison between different treatment modalities: a nationwide population-based cohort study in Taiwan. Transplant Proc. 2014;46(2):339-341. doi:10.1016\/j.transproceed.2013.11.080","DOI":"10.1016\/j.transproceed.2013.11.080"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Theodorakakou F, Fotiou D, Dimopoulos MA, Kastritis E. Solid organ transplantation in amyloidosis. Acta Haematol. 2020;143(4):352-364. doi:10.1159\/000508262","DOI":"10.1159\/000508262"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Naranjo-Escobar J, Manzi E, Posada JG, et al. Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience. Lupus. 2017;26(11):1157-1165. doi:10.1177\/0961203317696591","DOI":"10.1177\/0961203317696591"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Ciszek M, Kisiel B, Czerwinski J, et al. Kidney transplant recipients with rheumatic diseases: epidemiological data from the Polish transplant registries 1998-2015. Transplant Proc. 2018;50(6):1654-1657. doi:10.1016\/j.transproceed.2018.03.122","DOI":"10.1016\/j.transproceed.2018.03.122"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Lancieri M, Bustaffa M, Palmeri S, et al. An update on familial Mediterranean fever. Int J Mol Sci. 2023;24(11). doi:10.3390\/ijms24119584","DOI":"10.3390\/ijms24119584"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Kofman T, Grimbert P, Canoui-Poitrine F, et al. Renal transplantation in patients with AA amyloidosis nephropathy: results from a French multicenter study. Am J Transplant. 2011;11(11):2423-2431. doi:10.1111\/j.1600-6143.2011.03620.x","DOI":"10.1111\/j.1600-6143.2011.03620.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Sawinski D, Lim MA, Cohen JB, et al. Patient and kidney allograft survival in recipients with end-stage renal disease from amyloidosis. Transplantation. 2018;102(2):300-309. doi:10.1097\/TP.0000000000001930","DOI":"10.1097\/TP.0000000000001930"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Law S, Cohen O, Lachmann HJ, et al. Renal transplant outcomes in amyloidosis. Nephrol Dial Transplant. 2021;36(2):355-365. doi:10.1093\/ndt\/gfaa293","DOI":"10.1093\/ndt\/gfaa293"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Sarihan I, Caliskan Y, Mirioglu S, et al. Amyloid A amyloidosis after renal transplantation: an important cause of mortality. Transplantation. 2020;104(8):1703-1711. doi:10.1097\/TP.0000000000003043","DOI":"10.1097\/TP.0000000000003043"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Altindal M, Turkmen E, Yildirim T, et al. Kidney transplantation for end-stage renal disease secondary to familial Mediterranean fever. Clin Transplant. 2016;30(7):787-790. doi:10.1111\/ctr.12749","DOI":"10.1111\/ctr.12749"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Celik A, Saglam F, Dolek D, et al. Outcome of kidney transplantation for renal amyloidosis: a single-center experience. Transplant Proc. 2006;38(2):435-439. doi:10.1016\/j.transproceed.2006.01.003","DOI":"10.1016\/j.transproceed.2006.01.003"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Green H, Lichtenberg S, Rahamimov R, et al. Familial mediterranean fever is associated with increased mortality after kidney transplantation-a 19 years' single center experience. Transplantation. 2017;101(10):2621-2626. doi:10.1097\/TP.0000000000001681","DOI":"10.1097\/TP.0000000000001681"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Emiroglu R, Basaran O, Pehlivan S, et al. Effect of amyloidosis on long-term survival in kidney transplantation. Transplant Proc. 2005;37(7):2967-2968. doi:10.1016\/j.transproceed.2005.07.010","DOI":"10.1016\/j.transproceed.2005.07.010"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Abedi AS, Nakhjavani JM, Etemadi J. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc. 2013;45(10):3502-3504. doi:10.1016\/j.transproceed.2013.09.021","DOI":"10.1016\/j.transproceed.2013.09.021"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Keven K, Sengul S, Kutlay S, et al. Long-term outcome of renal transplantation in patients with familial Mediterranean fever amyloidosis: a single-center experience. Transplant Proc. 2004;36(9):2632-2634. doi:10.1016\/j.transproceed.2004.09.065","DOI":"10.1016\/j.transproceed.2004.09.065"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Yazisiz V, Yilmaz VT, Ucar I, et al. The use of anti-interleukin-1 agents and tumor necrosis factor-alpha inhibitors in renal transplant recipients. Arch Rheumatol. 2021;36(3):366-374. doi:10.46497\/ArchRheumatol.2021.8500","DOI":"10.46497\/ArchRheumatol.2021.8500"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Chelamcharla M, Javaid B, Baird BC, Goldfarb-Rumyantzev AS. The outcome of renal transplantation among systemic lupus erythematosus patients. Nephrol Dial Transplant. 2007;22(12):3623-3630. doi:10.1093\/ndt\/gfm459","DOI":"10.1093\/ndt\/gfm459"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Considine SW, Davis NF, McLoughlin LC, et al. Long-term outcomes of renal transplant in patients with end-stage renal failure due to systemic lupus erythematosus and granulomatosis with polyangiitis. Exp Clin Transplant. 2019;17(6):720-726. doi:10.6002\/ect.2019.0138","DOI":"10.6002\/ect.2019.0138"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Yap KS, Urowitz MB, Mahood Q, et al. The utility of lupus serology in predicting outcomes of renal transplantation in lupus patients: systematic literature review and analysis of the Toronto lupus cohort. Semin Arthritis Rheum. 2017;46(6):791-797. doi:10.1016\/j.semarthrit.2016.09.008","DOI":"10.1016\/j.semarthrit.2016.09.008"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Silva RM, Leal R, Marques MG, et al. Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a single-center 10-year experience. Transplant Proc. 2023;55(6):1396-1399. doi:10.1016\/j.transproceed.2023.04.018","DOI":"10.1016\/j.transproceed.2023.04.018"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:01:42Z","timestamp":1771326102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2026\/24\/1\/0\/36\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2023.0267","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}